Probi AB
STO:PROB
Intrinsic Value
Probi AB engages in the development and sale of probiotics. [ Read More ]
The intrinsic value of one PROB stock under the Base Case scenario is 130.45 SEK. Compared to the current market price of 204 SEK, Probi AB is Overvalued by 36%.
Valuation Backtest
Probi AB
Run backtest to discover the historical profit from buying and selling PROB stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Probi AB
Current Assets | 553m |
Cash & Short-Term Investments | 340m |
Receivables | 70.8m |
Other Current Assets | 142.3m |
Non-Current Assets | 984.1m |
Long-Term Investments | 71m |
PP&E | 199.8m |
Intangibles | 708.5m |
Other Non-Current Assets | 4.9m |
Current Liabilities | 68.5m |
Accounts Payable | 22.7m |
Other Current Liabilities | 45.8m |
Non-Current Liabilities | 42.5m |
Long-Term Debt | 36.9m |
Other Non-Current Liabilities | 5.6m |
Earnings Waterfall
Probi AB
Revenue
|
607.5m
SEK
|
Cost of Revenue
|
-410.7m
SEK
|
Gross Profit
|
196.8m
SEK
|
Operating Expenses
|
-211.1m
SEK
|
Operating Income
|
-14.3m
SEK
|
Other Expenses
|
13.7m
SEK
|
Net Income
|
-602k
SEK
|
Free Cash Flow Analysis
Probi AB
PROB Profitability Score
Profitability Due Diligence
Probi AB's profitability score is 48/100. The higher the profitability score, the more profitable the company is.
Score
Probi AB's profitability score is 48/100. The higher the profitability score, the more profitable the company is.
PROB Solvency Score
Solvency Due Diligence
Probi AB's solvency score is 75/100. The higher the solvency score, the more solvent the company is.
Score
Probi AB's solvency score is 75/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
PROB Price Targets Summary
Probi AB
According to Wall Street analysts, the average 1-year price target for PROB is 317.8 SEK .
Shareholder Return
PROB Price
Probi AB
Average Annual Return | -0.94% |
Standard Deviation of Annual Returns | 65.63% |
Max Drawdown | -74% |
Market Capitalization | 2.3B SEK |
Shares Outstanding | 11 394 125 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Probi AB engages in the development and sale of probiotics. The company is headquartered in Lund, Skane and currently employs 175 full-time employees. The Company’s activities are divided into two business areas: Functional Foods, which focuses on the probiotics application in food in partnership with food companies; and Consumer Healthcares, which develops, commercializes and sells Probi probiotics in collaboration with a range of entities, such as pharmaceutical companies and firms related to the production of probiotics and self-care goods. Its brands portfolio comprises two trademarks: Probi Digestis and Probi Defendum. The firm's partners include Danone, Skanemejerier, NextFoods, Sanum Polska, Heinz, Kraft Foods, and Institut Rosell, among others. The firm is a parent of Probi Food AB and Probi Feed AB.
Officers
The intrinsic value of one PROB stock under the Base Case scenario is 130.45 SEK.
Compared to the current market price of 204 SEK, Probi AB is Overvalued by 36%.